Solid Tumor
📧 Sign up to get email alerts when something new happens for Solid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: First in Human, Dose Escalation Study of AN4005 [Phase 1]
First-in-human, dose-escalation study of AN4005 in patients with advanced solid tumors and advanced lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: TGW211 for Click-Cleavable Imaging in HER2-Positive Cancers. [EARLY_Phase 1]
Clinical trial update indicating TGW211 as a click-cleavable imaging agent for HER2-positive cancers in an early-phase 1 study, currently re…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors [Phase 2]
This clinical trial update describes a Phase 2 study evaluating MHB036C in combination with MHB039A in patients with advanced breast cancer …
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies [Phase 1]
Phase 1 study evaluating the safety and tolerability of GEH200520/GEH200521 (18F) as a PET imaging tracer in patients with solid tumors; cur…
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment [Phase 1]
Aadi Bioscience is conducting a Phase 1 dose-escalation study to assess the safety and pharmacokinetics of Nab-Sirolimus in patients with lo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: A Study of YL201 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the investigational drug YL201 in patients with solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy [Phase 2]
Phase 2 clinical trial evaluating salvage radiation therapy for patients with metastatic cancer that progressed after systemic immunotherapy…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946 [Phase 1, Phase 2]
Phase 1/2 open-label study evaluating the safety, tolerability, PK and anti-tumor activity of YH42946 in non-small cell lung cancer and othe…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Testing MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With TSC1 or TSC2 Genetic Changes (MATCH - Subprotocol M) [Phase 2]
A phase 2 MATCH subprotocol M trial update evaluating MLN0128 (TAK-228) as a targeted treatment for cancers with TSC1 or TSC2 genetic change…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: A Phase I Study: PET Imaging of Cancer Patients Using [18F] 4-L-Fluoroglutamine (2S,4R) [Phase 1]
This update describes an ongoing Phase I clinical trial evaluating PET imaging with the radiotracer [18F] 4-L-Fluoroglutamine in patients wi…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: Study of ART6043 in Advanced/Metastatic Solid Tumors Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating ART6043 in patients with advanced/metastatic solid tumors is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-10-10Clinical Trial Update: Umbilical Cord Blood Transplantation From Unrelated Donors
This is an ongoing clinical trial evaluating umbilical cord blood transplantation from unrelated donors for hematologic diseases. The study …
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors [Phase 2]
A Phase 2 study evaluating SI-B003 alone and in combination with BL-B01D1 in patients with locally advanced or metastatic urothelial carcino…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: A Study of BL-B16D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors [Phase 1]
Phase 1 study evaluating BL-B16D1 in patients with unresectable locally advanced or metastatic breast cancer and other solid tumors is curre…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Personalised Immunotherapy Platform
Clinical trial update for a personalised immunotherapy platform; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases [EARLY_Phase 1]
A phase 1 trial is evaluating arginine in combination with whole-brain radiation therapy for brain metastases and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors [Phase 1, Phase 2]
An ongoing Phase 1/2 study investigates systemic VSV-IFNβ-NIS in combination with checkpoint inhibitors for select solid tumors. The trial i…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: A 1/2 Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ASKB589 in Patients With Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial update on ASKB589 assessing safety, tolerability, pharmacokinetics, and antitumor activity in locally advanced or m…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors [Phase 1]
This update describes a Phase 1 trial of R-5780-01 in combination with PD-1 checkpoint inhibitors for solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: AMT-116 in Patients With Advanced Solid Tumors [Phase 1]
This document describes an ongoing Phase 1 clinical trial of AMT-116 in patients with advanced solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849 [Phase 1, Phase 2]
This is a Phase I/II open-label clinical trial evaluating the safety, tolerability, PK, and preliminary efficacy of FB849 in patients with a…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: A Trial of HRS-6213 in Healthy Subjects and Patients With Solid Tumors [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating HRS-6213 in healthy subjects and patients with solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas [Phase 1]
CS5001 is being evaluated in a Phase 1 study for patients with advanced solid tumors and advanced lymphoma, with recruitment ongoing.
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Evaluation of Different Analysis Methods for Circulating Tumor Cells, Circulating Endothelial Cell, and Circulating Tumor DNA in Patient Followed for a Tumoral Pathology [NA]
A completed clinical trial evaluating different analysis methods for circulating tumor cells, circulating endothelial cells, and circulating…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Clinical Evaluation of 177Lu-AB-3PRGD2 in Various Solid Tumors With Integrin αvβ3 Positive Expression [Phase 1]
Phase 1 clinical evaluation of 177Lu-AB-3PRGD2 in various solid tumors with integrin αvβ3 expression. The study is currently recruiting.